All relevant documents and information for the meeting, including the notice and agenda, are or will be made available in the ‘Investor Relations’ section of ProQR’s website (www.proqr.com) under ‘Financial Information’. The documents will also be made available on the
Chief Financial Officer
T: +1 415 231 6431
Source: ProQR Therapeutics N.V.